Effect of post-treatment MRD status on subsequent outcomes according to chemotherapy intensity in acute myeloid leukemia (AML).
Michael J HochmanMegan OthusRoland B WalterCarole ShawKelda GardnerMary-Elizabeth M PercivalAnna B HalpernPaul C HendrieBrenda M SandmaierElihu H EsteyPublished in: Leukemia & lymphoma (2021)